Doxapram hydrochloride anhydrous

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue。.

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue。.

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue。.

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue。.

Anti-DOLK dolichol kinase, 25ul UN 1687 6.1 PG2

Anti-MPDU1 mannose-P-dolichol utilization defect 1, 25ul UN

Synonym(s): Hexafluorozirconic acid, Hydrogen hexafluorozirconate Formula: H2ZrF6 Formula weight: 207.22 CAS Number: 12021-95-3 UN Number: UN2922 Hazard Class: 8 Packing Group: II Harmonized Tariff Code:  2826.

Doxapram-d 5 (hydrochloride) is deuterium labeled Doxapram (hydrochloride).Appearance:SolidIn Vitro:Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during

Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor with IC 50 s of 1.57 and 308 nM for tg DHFR ( Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively. Fanotaprim has the potential for the research of toxoplasmosis.In VitroFanotaprim

Application HA-1077 dihydrochloride has been used: to relax cantilevers in the functional assessment of isolated coronary arteries to investigate the effect of azaindole-1, fasudil on acute hypoxic pulmonary vasoconstriction (HPV) Biochem/physiol